###### What\'s new?

By now, the currently available low-dose X-ray imaging protocol is operated at 23 nGy (fluoroscopy) and at 120 nGy (cine-loop).Siemens AG has recently developed a new very low dose protocol especially designed for EP procedures, which is operated at 8 nGy (fluoroscopy) and at 36 nGy (cine-loop).This study demonstrates that working at these lowest-dose levels is feasible and safe, the reported dose--area products are very low when compared with previously published X-ray dose data.

Introduction {#s1}
============

Fluoroscopy is the basic imaging modality in the electrophysiology (EP) catheterization laboratory. For complex EP interventions, in particular atrial fibrillation ablation procedures, 3D navigation systems, and preprocedural 3D imaging are commonly employed to supplement fluoroscopic imaging. Previous studies showed that the use of 3D navigation systems significantly decreases radiation exposure in EP procedures.^[@EUV364C1]--[@EUV364C4]^

Adaptive use of X-ray collimation and principles of radiological protection should generally be applied to keep radiation exposure as low as possible.^[@EUV364C5]^ Since fluoroscopy systems are technically optimized for high-resolution angiography, there is room for dose reduction when used for EP interventions not requiring detailed resolution. By now, the lowest available clinical acquisition settings for fluoroscopic EP procedures on an *Artis zee* angiography system (Siemens AG, Forchheim, Germany) are operated at 23 nGy detector entrance dose per fluoroscopy pulse. In this study, we present and evaluate a new very low dose fluoroscopy protocol (Siemens AG), which was especially designed for EP interventions, offering fluoroscopy operated at 8 nGy detector entrance dose per fluoroscopy pulse.

Methods {#s2}
=======

Study overview {#s2a}
--------------

From October 2014 to March 2015, overall 140 consecutive patients underwent an EP study on an *Artis zee* angiography system. All patients gave written informed consent before the procedure. The study was approved by the ethics committee. From October 2014 to December 2014, fluoroscopy was operated at the standard available low-dose EP imaging protocol. From January 2015 to March 2015, fluoroscopy was operated at a new very low dose protocol. For each EP study, procedural data were documented and stored for later analysis. *Figure [1](#EUV364F1){ref-type="fig"}* shows an example of a fluoroscopic image using the old standard low dose (*A*) and the new lowest dose (*B*) acquisition protocol. Figure 1Anterior-posterior view fluoroscopic acquisitions using the old low-dose protocol (*A*) and the new lowest-dose protocol (*B*). The images show coronary sinus, circular mapping, and RF-ablation catheters.

Fluoroscopy protocols {#s2b}
---------------------

The detector entrance dose settings of the available standard low-dose and the new lowest-dose protocols are summarized in *Table [1](#EUV364TB1){ref-type="table"}*. In both protocols, cine-loops were acquired with 7.5 fps using a tube currency of 81 kV. Fluoroscopic images were acquired with 3 fps using a tube currency of 90 kV. Table 1Detector entrance dose settings for low-dose and lowest-dose protocolDetector entrance doseLow dose (nGy)Very low dose (nGy)Cine-loop acquisition12036Fluoroscopy acquisition238

Ablation procedures {#s2c}
-------------------

All EP procedures included in this study were carried out in the same laboratory by four experienced operators. For analysis, patient details were documented and the procedures were divided into complex left atrial procedures (atrial fibrillation- and atypical flutter-ablation) and standard procedures (typical flutter-, AVNRT-, WPW-, and PVC-ablation). The procedures were performed according to the current clinical standards. All left atrial and PVC-ablation procedures were supported by CARTO 3 (Biosense Webster, Diamond Bar, CA, USA) or EnSite Velocity (St Jude Medical, St Paul, MN, USA).

Procedural data {#s2d}
---------------

For all procedures, X-ray times, dose--area products (DAPs; µGym²), and Air kerma (AK; mGy) values were documented. The AK represents absorbed radiation dose and correlates with deterministic radiation effects. The DAP is defined as absorbed dose multiplied by the irradiated area and it correlates with stochastic radiation effects. For left atrial procedures, procedural times for each step (puncture, mapping, and ablation) as well as cine-loop times, angulations and doses were documented separately. Procedure and radiofrequency (RF) times and complications were documented as further study parameters.

Clinical outcome {#s2e}
----------------

A 6-month follow-up assessed the clinical outcome of the ablation procedures. For atrial fibrillation and atrial flutter, any asymptomatic or symptomatic episode lasting \>30 s in a routinely performed 7-day long-term electrocardiogram (ECG) or symptomatic arrhythmic episodes lasting \>30 s without ECG documentation were counted as a recurrence. In AVNRT, WPW, and PVC patients, symptomatic arrhythmic episodes or ECG documentations of the clinical arrhythmia were counted as a recurrence.

Statistics {#s2f}
----------

The mean values were calculated as the arithmetic average ± standard deviation. Comparisons between groups were made by *χ*^2^ test or Fisher\'s exact test, for categorical variables and unpaired *t*-test or one-way analysis of variance for normally distributed variables. A *P*-value of \<0.05 was considered statistically significant. Cine-loop doses were calculated per cine-loop frame and fluoroscopy dose was calculated per fluoroscopy time.

Results {#s3}
=======

Overall 100 left atrial and 40 standard procedures were analysed, including 237 cine-loops. All operators were able to carry out the procedures using the very low X-ray dose protocol. Switching to higher dose levels was not necessary in any case. Relevant patient characteristics and treated arrhythmias are summarized in *Tables [2](#EUV364TB2){ref-type="table"}* and *[3](#EUV364TB3){ref-type="table"}*. Table 2Patient details of both groupsPatient details (*n* = 140)Low-dose groupLowest-dose group*P*-ValueAge (years)57.3 ± 15.358.8 ± 16.20.57Female sex (%)35%32%0.71BMI (kg/m²)26.2 ± 2.925.9 ± 3.60.58Body surface area (m²)2.01 ± 0.171.98 ± 0.240.56Ejection fraction (%)55.2 ± 9.3%54.5 ± 10.4%0.55Hypertension, *n* (%)74 (53%)83 (59%)0.28Diabetes mellitus, *n* (%)15 (11%)11 (8%)0.41Coronary artery disease, *n* (%)17 (12%)25 (18%)0.18Table 3Numbers of treated arrhythmias in both groupsTreated arrhythmia (*n* = 140)Low-dose groupLowest-dose groupAtrial fibrillation, *n*3532Atypical flutter, *n*1518Typical flutter, *n*53Accessory pathway, *n*33AVNRT, *n*68PVC, *n*66

The procedural and clinical outcome data are shown separately for left atrial and for standard procedures (*Tables [4](#EUV364TB4){ref-type="table"}* and *[5](#EUV364TB5){ref-type="table"}*). Both reported complications were arteriovenous fistulas. Table 4Procedural and clinical data of left atrial proceduresComplex procedures (*n* = 100)Low-dose groupLowest-dose group*P*-ValueProcedure time (min)132.6 ± 35.7126.7 ± 34.70.40Puncture time (min)12.9 ± 5.211.3 ± 6.70.18Mapping time (min)11.7 ± 4.310.6 ± 4.80.23RF time (min)53.8 ± 26.150.4 ± 29.40.54Complications, *n*111.0X-ray time (min)10.1 ± 7.68.6 ± 6.20.28Six-month follow-up success (%)70%72%0.82Table 5Procedural and clinical data of standard proceduresStandard procedures (*n* = 40)Low-dose groupLowest-dose group*P*-ValueProcedure time (min)72.3 ± 20.985.2 ± 44.10.24RF time (min)10.1 ± 9.912.2 ± 14.70.60Complications, *n*001.0X-ray time (min)7.1 ± 5.48.7 ± 6.40.40Six-month follow-up success (%)95%95%1.0

The use of the very low dose protocol facilitated a mean X-ray dose reduction of 77.3% for complex and of 76.6% for standard procedures. *Figure [2](#EUV364F2){ref-type="fig"}* shows the overall resulting X-ray DAPs. *Table [6](#EUV364TB6){ref-type="table"}* summarizes AK values, DAPs per frame regarding different C-arm angulations, and DAPs per fluoroscopy time. Table 6Air kerma values, cine-loop DAPs/frame for different angulations, and DAP per fluoroscopy timeParameterLow-dose groupLowest-dose group*P*-ValueCumulative AK standard (mGy)65.4 ± 75.515.6 ± 19.8\<0.01Cumulative AK complex (mGy)110.7 ± 67.624.6 ± 17.68\<0.01Cine-loop DAP (µGym²)170.2 ± 179.050.1 ± 37.8\<0.01Cine-loop DAP/frame LAO (µGym²)4.5 ± 6.31.0 ± 0.7\<0.01Cine-loop DAP/frame anterior-posterior (µGym²)1.3 ± 0.70.4 ± 0.4\<0.01Cine-loop DAP/frame RAO (µGym²)2.6 ± 0.80.74 ± 0.7\<0.01Fluoroscopy DAP/s (µGym²/s)1.73 ± 1.210.42 ± 0.24\<0.01Figure 2X-ray DAPs resulting from standard low-dose and new lowest-dose settings in standard and complex left atrial procedures. The reduction of DAPs was highly significant (*P* \< 0.01).

Limitations {#s4}
===========

The study was based on retrospective analysis of procedural data. Owing to national radiological protection law, it was not possible to design the study as a randomized controlled trial. Basically, X-ray dose levels are affected by angulation of the angiography system and collimation. The documentation of angulation was only available for cine-loops. However, we expected that the operators applied collimation and angulation in their same used manner when working at low-dose and lowest-dose fluoroscopy.

Discussion {#s5}
==========

In this study, we present a new very low dose imaging protocol which was especially designed for EP procedures. To our knowledge, it is the first evaluation of these acquisition settings for EP procedures. The resulting dose levels of 199.7 ± 159.6 µGym² (DAP) and 24.6 ± 17.68 mGy (AK) for left atrial ablation procedures are very low when compared with previously published DAP levels between 789 and 11 199 µGym².^[@EUV364C6]--[@EUV364C10]^ The AK and DAP data show that lowest-dose fluoroscopy can significantly extenuate both the deterministic (e.g. skin injuries) as well as stochastic (e.g. risk of malignancy) effects of radiation exposure.

In the low-dose and lowest-dose acquisition protocols, the X-ray tube voltage was identically chosen (81 kV for cine-loops and 90 kV for fluoroscopy) which prevented that softer X-ray radiation might create better image quality in one group but be more harmful to tissue.

In the past years, the increased use of 3D navigation systems and operators\' awareness for radiological protection led to a reduction of X-ray exposure in EP interventions, especially in complex procedures.^[@EUV364C1]--[@EUV364C3]^ Recent publications demonstrated that completely non-fluoroscopic ablation procedures based on 3D systems and intracardiac echocardiography are feasible.^[@EUV364C11]--[@EUV364C15]^ However, current real-world data, as recently presented in a European Heart Rhythm Association survey by Estner *et al*.,^[@EUV364C16]^ show that fluoroscopy still remains the basic imaging modality in EP procedures. For complex procedures, a median fluoroscopy time of 16 min and a cumulative DAP of 6100 µGym² are reported. As long as fluoroscopy remains a commonly applied imaging technology, the implementation of lowest-dose fluoroscopy protocols to achieve a significant reduction of radiation exposure remains highly preferable.

Nof *et al*.^[@EUV364C17]^ recently published the successful implementation of a custom made very low dose fluoroscopy protocol allowing a significant reduction of radiation doses. In their study, the correlation of patient body mass index (BMI) and system angulation on radiation exposure was evaluated, which showed an exponential increase of radiation dose depending on patient BMI and left anterior oblique (LAO) angulation.

Previous paediatric studies dealing with strategies of dose reduction in EP procedures showed that the use of radiation safety protocols, lowered detector entrance doses, and individual adaption of fluoroscopy frame rates leads to a significant reduction in X-ray dose exposure without increasing procedure times, complication rates, or outcome.^[@EUV364C18]--[@EUV364C23]^ Also the removal of the scatter grid, which resulted in poorer image quality, has been shown to reduce radiation by as much as two-fold.^[@EUV364C24]^

From an operator standpoint, lowest X-ray dose levels create a different, reduced image quality (*Figure [1](#EUV364F1){ref-type="fig"}*). However, although unfamiliar, the new image quality did not significantly affect procedure times, clinical outcome, or RF times and did not result in higher complication rates.

Conclusion {#s6}
==========

The data demonstrate that applying lowest dose imaging protocols especially designed for EP procedures reduce X-ray dose levels by 77% compared with the current standard low-dose protocol. Regarding radiological protection, operating at lowest-dose settings should become standard in EP procedures.
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